Would Mean Platelet Volume/Platelet Count Ratio Be Used as A Novel Formula to Predict 22q11.2 Deletion Syndrome?
Tarih
2016Yazar
Gokturk, Bahar
Guner, Sukru Nail
Kara, Reyhan
Kirac, Mine
Keles, Sevgi
Artac, Hasibe
Zamani, Ayse Gul
Yildirim, Mahmut Selman
Reisli, Ismail
Üst veri
Tüm öğe kaydını gösterÖzet
Background: The diagnosis of 22q11.2 deletion syndrome depends on a time-consuming and expensive method, fluorescence in situ hybridisation (FISH).
Objectives: We aimed to determine new parameters which can aid for in the diagnosis of 22q11.2 deletion syndrome.
Methods: Twenty two patients with 22q11.2 or 10p13 deletion were evaluated retrospectively.
Results: Facial-dysmorphism and mental-motor retardation were detected in 100% of patients. Mean platelet (PLT) counts were lower (224,980 versus 354,000, p = 0.001), mean PLT volume (MPV) (9.95 versus 7.07, p = 0.002), and MPV/PLTx10(5) ratios (5.36 versus 2.08, p < 0.001) were higher in patients with 22q11.2 deletion compared with the control group. Area under the receiver-operator characteristic (ROC) curve was 0.864, sensitivity was 84.6%, specificity was 90.9%, positive predictive value (PPV) was 91.7%, and negative predictive value (NPV) was 83.3% when MPV was 8.6. Area under ROC curve was 0.864, sensitivity was 76.9%, specificity was 90.1%, PPV was 90.1%, and NPV was 76.3% when PLT was 265,500. Area under ROC curve was 0.906, sensitivity was 84.6%, specificity was 100%, PPV was 100%, and NPV was 84.6% when MPV/PLTx10(5) was 3.3. Expression of PLT surface markers which were not in the GPIb-V-IX receptor complex (CD61, CD41a) increased as the surface area increased, but markers which were in a complex (CD42a, CD42b) did not change.
Conclusions: High MPV/PLT value can be a good predictor for the diagnosis of 22q11.2 deletion syndrome. We suggest that in patients with facial dysmorphism and retardation in neurodevelopmental milestones and if MPV >= 8.6fl, MPV/PLTx10(5) ratio >= 3.3 and PLT count <= 265,500/mm(3), the patients should be tested by FISH analysis to confirm the 22q11.2 deletion. If there are no macrothrombocytes, the 10p13 deletion should be tested in suspected cases.
Bağlantı
http://hdl.handle.net/11727/9785Koleksiyonlar
İlgili Öğeler
Başlık, yazar, küratör ve konuya göre gösterilen ilgili öğeler.
-
Comment on "Treatment of male pattern alopecia with platelet-rich plasma: A double-blind controlled study with analysis of platelet number and growth factor levels''
Altunel, Cemile Tugba; Gulec, Tulin (2019) -
Investigation of the Relationship Between White Blood Cell Count, Platelet Count, and Mean Platelet Volume Values and Clinical Complications in Patients with Sickle Cell Anemia
Tanrikulu, Funda Pepedil; Olcuoglu, Rukiye; Kilinc, Sevtap; Cakmak, Eda; Kozanoglu, Ilknur (2023) -
Positive effect of platelet rich fibrin on osseointegration
Oncu, Elif; Bayram, Burak; Kantarci, Alpdogan; Gulsever, Serap; Alaaddinoglu, Emine-Elif (2016)Background: Leukocyte-platelet rich fibrin (L-PRF) is a second generation platelet concentrate clinically used to accelerate tissue healing and bone regeneration. Achieving reduced implant osseointegration time could provide ...